DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 10 of 22 descriptions
Filter by
Reset
|
No.
薬物名（臨床試験情報から抽出）
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
指定難病告示番号
1
EU-approved
RoActemra
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
1. EU-approved
RoActemra
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
1. EU-approved
RoActemra
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
💬
1. EU-approved
RoActemra
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
2
RoActemra
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
2.
RoActemra
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
2.
RoActemra
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
11件:
40
40
,
41
,
44
,
46
,
50
,
51
,
86
,
107
,
266
,
271
,
331
💬
2.
RoActemra
×
告示番号
日本語名
英語名
40
高安動脈炎;大動脈炎症候群
Takayasu arteritis
41
巨細胞性動脈炎;側頭動脈炎
Giant cell arteritis
44
多発血管炎性肉芽腫症;ウェゲナー肉芽腫症
Wegener granulomatosis
46
悪性関節リウマチ
Malignant rheumatoid arthritis
50
皮膚筋炎／多発性筋炎
Dermatomyositis
51
全身性強皮症
Scleroderma
86
肺動脈性肺高血圧症
Pulmonary arterial hypertension
107
若年性特発性関節炎
Juvenile idiopathic arthritis
266
家族性地中海熱
Familial mediterranean fever
271
強直性脊椎炎
Ankylosing spondylitis
331
特発性多中心性キャッスルマン病
Idiopathic multicentric castleman disease
3
RoActemra
(R)
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
3.
RoActemra
(R)
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
3.
RoActemra
(R)
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
💬
3.
RoActemra
(R)
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
4
ROACTEMRA
- 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE
ROACTEMRA
- 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4
...
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
4.
ROACTEMRA
- 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
4.
ROACTEMRA
- 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
2件:
46
46
,
51
💬
4.
ROACTEMRA
- 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
51
全身性強皮症
Scleroderma
5
ROACTEMRA
- 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO
ROACTEMRA
- 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4M
...
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
5.
ROACTEMRA
- 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
5.
ROACTEMRA
- 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
💬
5.
ROACTEMRA
- 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
6
RoActemra
162 mg
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
6.
RoActemra
162 mg
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
6.
RoActemra
162 mg
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
2件:
46
46
,
51
💬
6.
RoActemra
162 mg
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
51
全身性強皮症
Scleroderma
7
RoActemra
162 mg solution for injection in pre-filled syringe
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
7.
RoActemra
162 mg solution for injection in pre-filled syringe
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
7.
RoActemra
162 mg solution for injection in pre-filled syringe
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
41
41
💬
7.
RoActemra
162 mg solution for injection in pre-filled syringe
×
告示番号
日本語名
英語名
41
巨細胞性動脈炎;側頭動脈炎
Giant cell arteritis
8
RoActemra
162 mg solution injectable en seringue préremplie
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
8.
RoActemra
162 mg solution injectable en seringue préremplie
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
8.
RoActemra
162 mg solution injectable en seringue préremplie
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
💬
8.
RoActemra
162 mg solution injectable en seringue préremplie
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
9
RoActemra
162 mg soluzione iniettabile in siringa preriempita
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
9.
RoActemra
162 mg soluzione iniettabile in siringa preriempita
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
9.
RoActemra
162 mg soluzione iniettabile in siringa preriempita
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
50
50
💬
9.
RoActemra
162 mg soluzione iniettabile in siringa preriempita
×
告示番号
日本語名
英語名
50
皮膚筋炎／多発性筋炎
Dermatomyositis
10
RoActemra
20 mg/ml concentrado para solución para perfusión
1件:
Tocilizumab
Tocilizumab
(
Roactemra
)
1件:
Tocilizumab
Tocilizumab
💬
10.
RoActemra
20 mg/ml concentrado para solución para perfusión
×
Name
Other Names
Tocilizumab
Tocilizumab (USAN/INN)
Tocilizumab (genetical recombination) (JAN)
Actemra (TN)
トシリズマブ
アクテムラ
1件:
IL6R
IL6R
💬
10.
RoActemra
20 mg/ml concentrado para solución para perfusión
×
Name
Full Name
IL6R
interleukin 6 receptor
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
💬
10.
RoActemra
20 mg/ml concentrado para solución para perfusión
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis